

IntraBio, co-founded by Department of Pharmacology academics Professors Fran Platt, Antony Galione and Grant Churchill, ran a successful international clinical trial for a new drug Aqneursa which showed significantly improved neurological outcomes over a 12 week period for a cohort of 60 patients, aged four years and over, with a confirmed diagnosis of NPC compared to a control group. Despite the recent proliferation of Drug Discovery Units in many Universities, it is nevertheless still rare for academics to take a new molecular entity from pre-clinical to phase III clinical trials culminating in regulatory approval and marketing for patients. The first prescriptions for Aqneursa have already been written.
NPC is a rare genetic disease that results in progressive neurological symptoms and organ dysfunction. It is caused by changes in either the NPC1 or NPC2 gene, affecting the transport of cholesterol and other lipids out of the lysosome. As a result, cells do not function as they should, ultimately causing organ damage. On average, individuals affected by this devastating disease only live for about 13 years. The new drug, Aqneursa, is only the third drug approved for the treatment of NPC, including miglustat, which was the first drug to be approved for lysosomal storage diseases that was developed by the Platt laboratory.
Read the full story on the Department of Pharmacology website.
more recommended stories
Brain’s Biological Age Emerges as Key Health Risk Indicator
Clinical Significance of Brain Age in.
Children’s Health in the United States is Declining!
Summary: A comprehensive analysis of U.S..
Autoimmune Disorders: ADA2 as a Therapeutic Target
Adenosine deaminase 2 (ADA2) has emerged.
Is Prediabetes Reversible through Exercise?
150 Minutes of Weekly Exercise May.
New Blood Cancer Model Unveils Drug Resistance
New Lab Model Reveals Gene Mutation.
Healthy Habits Slash Diverticulitis Risk in Half: Clinical Insights
Healthy Habits Slash Diverticulitis Risk in.
Caffeine and SIDS: A New Prevention Theory
For the first time in decades,.
Microbial Metabolites Reveal Health Insights
The human body is not just.
Reelin and Cocaine Addiction: A Breakthrough Study
A groundbreaking study from the University.
Preeclampsia and Stroke Risk: Long-Term Effects
Preeclampsia (PE) – a hypertensive disorder.
Leave a Comment